🔎 Trials Near Me

Akèy › Limfòm Burkitt › Utah › Salt Lake City

Etid klinik pou Limfòm Burkitt nan Salt Lake City, UT

7 etid pou Limfòm Burkitt ap chèche patisipan nan sit nan ak bò kote Salt Lake City (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

Ap rekriteFaz 3
  • Huntsman Cancer Institute/University of Utah, Salt Lake City
Laj 18 a 39 · Tout sèks · Mizajou Oct 2, 2026 · NCT03150693

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

Ap rekriteFaz 1/2
  • Intermountain - Primary Children's Hospital ( Site 1014), Salt Lake City
6 Months – 25 Years · Tout sèks · Mizajou Sep 17, 2026 · NCT06395103

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Ap rekriteFaz 2
  • Primary Children's Hospital, Salt Lake City
Laj 1 a 30 · Tout sèks · Mizajou Sep 1, 2026 · NCT04546399

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Ap rekriteFaz 3
  • Primary Children's Hospital, Salt Lake City
365 Days – 25 Years · Tout sèks · Mizajou Aug 25, 2026 · NCT03959085

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

Ap rekriteFaz 2
  • Primary Children's Hospital, Salt Lake City
Laj 7 a 25 · Tout sèks · Mizajou Aug 19, 2026 · NCT05082519

Etid Limfòm Burkitt nan lòt vil

Lòt etid nan Salt Lake City

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.